- Home
- NX vs CBLL Comparison
NX vs CBLL Comparison
Compare NX & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NX
- CBLL
- Stock Information
- Founded
- NX 1927
- CBLL 2014
- Country
- NX United States
- CBLL United States
- Employees
- NX N/A
- CBLL N/A
- Industry
- NX Metal Fabrications
- CBLL
- Sector
- NX Industrials
- CBLL
- Exchange
- NX Nasdaq
- CBLL Nasdaq
- Market Cap
- NX 1.1B
- CBLL 927.1M
- IPO Year
- NX N/A
- CBLL 2024
- Fundamental
- Price
- NX $22.90
- CBLL $19.09
- Analyst Decision
- NX Strong Buy
- CBLL Strong Buy
- Analyst Count
- NX 1
- CBLL 5
- Target Price
- NX $38.00
- CBLL $33.25
- AVG Volume (30 Days)
- NX 716.4K
- CBLL 337.5K
- Earning Date
- NX 03-06-2025
- CBLL 02-14-2025
- Dividend Yield
- NX 1.41%
- CBLL N/A
- EPS Growth
- NX N/A
- CBLL N/A
- EPS
- NX 0.90
- CBLL N/A
- Revenue
- NX $1,277,862,000.00
- CBLL $60,041,000.00
- Revenue This Year
- NX $50.17
- CBLL $44.86
- Revenue Next Year
- NX $2.87
- CBLL $26.56
- P/E Ratio
- NX $25.44
- CBLL N/A
- Revenue Growth
- NX 13.03
- CBLL 131.62
- 52 Week Low
- NX $21.48
- CBLL $18.69
- 52 Week High
- NX $39.31
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- NX 34.56
- CBLL N/A
- Support Level
- NX $21.48
- CBLL N/A
- Resistance Level
- NX $24.22
- CBLL N/A
- Average True Range (ATR)
- NX 0.81
- CBLL 0.00
- MACD
- NX -0.05
- CBLL 0.00
- Stochastic Oscillator
- NX 36.01
- CBLL 0.00
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its three operating segments are North American Fenestration being the key revenue driver, European Fenestration, and North American Cabinet Components. Geographically, it derives a majority of revenue from the United States.
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.